A study of growth, development and maturation in adolescents with atopic dermatitis who receive upadacitinib

22/08/2023
09/01/2025
EU PAS number:
EUPAS106180
Study
Ongoing
Documents
Study protocol
Initial protocol
English (233.49 KB - PDF) View document
Study results
Study report
Other information